ReviewMolecules (Basel, Switzerland)2018
Fungal Metabolite Antagonists of Plant Pests and Human Pathogens: Structure-Activity Relationship Studies.
Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 40 citations in OpenAlex.
- Phytochemical and bioactive insights into endophytic fungi from Wrightia tinctoria with emphasis on Xylaria rohrensis metabolites potential.Scientific reports · 2025Article
- Combinatorial Synthesis of Indole Derivatives as Anti-oomycetes Agents.Combinatorial chemistry & high throughput screening · 2024Article
- Article
- Phytotoxic Metabolites Produced by Fungi Involved in Grapevine Trunk Diseases: Progress, Challenges, and Opportunities.Plants (Basel, Switzerland) · 2022Review
- The Assignment of the Absolute Configuration of Non-Cyclic Sesquiterpenes by Vibrational and Electronic Circular Dichroism: The Example ofBiomolecules · 2021Article
- In Vitro and In Vivo Toxicity Evaluation of Natural Products with Potential Applications as Biopesticides.Toxins · 2021Article
- In Vitro Antibacterial, Antifungal, Nematocidal and Growth Promoting Activities ofJournal of fungi (Basel, Switzerland) · 2021Article
- Farnesane-Type Sesquiterpenoids with Antibiotic Activity fromAntibiotics (Basel, Switzerland) · 2021Article
- Characterization and phytotoxicity of ophiobolins produced byMycoscience · 2021Article
- The potential use of the Penicillium chrysogenum antifungal protein PAF, the designed variant PAFMicrobial biotechnology · 2020Article
- Review
- Dihydroisocoumarins produced by Diaporthe cf. heveae LGMF1631 inhibiting citrus pathogens.Folia microbiologica · 2020Article
- Rabenchromenone and Rabenzophenone, Phytotoxic Tetrasubstituted Chromenone and Hexasubstituted Benzophenone Constituents Produced by the Oak-Decline-Associated FungusJournal of natural products · 2020Article
- Phytotoxic Metabolites Isolated fromToxins · 2020Article
- Isolation and Bioactivity of Secondary Metabolites from Solid Culture of the Fungus,Biomolecules · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungi are able to produce many bioactive secondary metabolites that belong to different classes of natural compounds. Some of these compounds have been selected for their antagonism against pests and human pathogens and structure-activity relationship (SAR) studies have been performed to better understand which structural features are essential for the biological activity. In some cases, these studies allowed for the obtaining of hemisynthetic derivatives with increased selectivity and stability in respect to the natural products as well as reduced toxicity in view of their potential practical applications. This review deals with the SAR studies performed on fungal metabolites with potential fungicidal, bactericidal, insecticidal, and herbicidal activities from 1990 to the present (beginning of 2018).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.